(JULY 15, 2022) UVM Cancer Center director Randall Holcombe, M.D., M.B.A., told the Burlington Free Press that the center, together with the Dartmouth Cancer Center and Vermonters Taking Action Against Cancer, has launched a campaign to increase screening for lung cancer — the leading cause of cancer death in Vermont and the country.

(JULY 12, 2022) John King, M.D., M.P.H., professor of family medicine, who practices in Milton, urges all high-risk patients to get screened for lung cancer, according to the Milton Independent. The Dartmouth and the University of Vermont Cancer Centers have named Milton an area of focus to promote early detection of lung cancer.

(JULY 11, 2022) Beth Zigmund, M.D., associate professor of radiology and director of lung cancer screening for UVMMC, explained the benefits of early detection and treatment as part of the UVM and Dartmouth cancer centers’ newly launched partnership with the state’s cancer coalition, NBC5 reported.

In a Journal of American Medical Association study, researchers - including UVM Professor and UVM Cancer Center member Brian Sprague, Ph.D. - found that 3D screening with digital breast tomosynthesis had certain benefits compared to breast cancer screening with conventional 2D digital mammography.

In a formal ceremony held at the University of Vermont’s Larner College of Medicine on June 28, 2022, Associate Professor of Surgery William Brundage, M.D., was invested as the inaugural Green and Gold Professor in the Division of Otolaryngology, Head and Neck Surgery.

A $5.5 million gift to establish the Osher Center for Integrative Health at UVM will expand access to complementary therapies for UVM Cancer Center patients.

Yvonne Janssen-Heininger, Ph.D., professor of pathology and laboratory medicine at the UVM Larner College of Medicine, is a 2022 recipient of the University Distinguished Professor Award. This title is a career appointment, and is the highest academic honor that UVM can bestow upon a member of the faculty.

In a first-of-its-kind study, research from the University of Vermont Cancer Center has linked phthalates, commonly called the “everywhere chemical,” to higher incidence of specific childhood cancers.

In recent years, total neoadjuvant treatment—a potent new therapy for advanced colorectal cancer—has emerged as the standard of care. But the treatment can be harsh, impacting quality of life for many patients. A new study published in Clinical Colorectal Cancer by a team of researchers affiliated with the University of Vermont Cancer Center highlights a variety of new colorectal cancer treatments that take into account both a patient’s likely health outcome and quality of life factors.

Frances Carr, Ph.D., professor of pharmacology at the Larner College of Medicine at the University of Vermont and UVM Cancer Center member, has been elected to the American Association for the Advancement of Science Fellows Class of 2021.

UVM Cancer Center researchers contributed to the establishment of a breast pre-cancer atlas, which establishes the molecular and cellular properties of early-stage breast cancer and is the result of a six-year, National Cancer Institute-funded, collaborative initiative.

The UVM Cancer Center Summer Student Fellowships in Cancer Research provide $3,000 stipends to graduate and medical students for cancer-related research projects, overseen by senior faculty members affiliated with the center.